Sanofi (SNYNF)
OTCMKTS
· Delayed Price · Currency is USD
106.45
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT
Sanofi Employees
Sanofi had 82,878 employees as of December 31, 2024. The number of employees decreased by 3,210 or -3.73% compared to the previous year.
Employees
82,878
Change (1Y)
-3,210
Growth (1Y)
-3.73%
Revenue / Employee
$589,029
Profits / Employee
$82,148
Market Cap
129.74B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 82,878 | -3,210 | -3.73% |
| Dec 31, 2023 | 86,088 | -5,485 | -5.99% |
| Dec 31, 2022 | 91,573 | -3,869 | -4.05% |
| Dec 31, 2021 | 95,442 | -3,970 | -3.99% |
| Dec 31, 2020 | 99,412 | -997 | -0.99% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| SS Innovations International | 378 |
| Endo Inc. | 3,116 |
| Elite Pharmaceuticals | 64 |
| Northwest Biotherapeutics | 25 |
| Glass House Brands | 374 |
| CytoDyn | 9 |
| American Oncology Network | 1,914 |
| Longduoduo Company | 49 |
Sanofi News
- 8 hours ago - Sanofi Sales, Profit Beat Expectations on Higher Demand for Skin, Asthma Drug - WSJ
- 11 hours ago - Sanofi beats top-line and bottom-line estimates; reaffirms FY25 outlook - Seeking Alpha
- 12 hours ago - Sanofi's quarterly profit beats estimates on Dupixent boost, newer products - Reuters
- 12 hours ago - Press Release: Sanofi: strong Q1 performance and 2025 guidance confirmed - GlobeNewsWire
- 1 day ago - Novartis and Sanofi CEOs say EU should raise drug prices in face of tariffs - Reuters
- 1 day ago - Pharma bosses call for higher drug prices in EU to counter tariff threat - Financial Times
- 6 days ago - Sanofi-Regeneron's Dupixent gets FDA's nod for skin condition - Reuters
- 6 days ago - Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria - GlobeNewsWire